The Food and Drug Administration Vaccines and Related Biological Products Advisory Committee meets to discuss the emergency use authorization requests for COVID-19 vaccine candidate from Pfizer that has released some Phase 3 trial data.
RELATED: https://bit.ly/2Z2VOoN
» Subscribe to USA TODAY: http://bit.ly/1xa3XAh
» Watch more on this and other topics from USA TODAY: https://bit.ly/3f4hzKx
» USA TODAY delivers current local and national news, sports, entertainment, finance, technology, and more through award-winning journalism, photos, videos and VR.
source